NR
NeurAxis, Inc. (NRXS)
AMEX·Healthcare·Biotechnology
$7.62
-6.27%
Mkt Cap $61.25M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $850.00K | $968.00K | +13.88% | -$0.21 | -$0.17 | +20.93% | — | — |
| Q4 2025 Nov 10, 2025 | — | $811.41K | — | — | -$0.24 | — | — | — |
| Q3 2025 Aug 12, 2025 | — | $894.09K | — | — | -$0.22 | — | — | — |
| Q2 2025 May 12, 2025 | — | $895.65K | — | -$0.24 | -$0.31 | -29.17% | — | — |
| Q1 2025 Mar 20, 2025 | — | $761.16K | — | — | -$0.21 | — | — | — |
| Q4 2024 Nov 12, 2024 | — | $666.63K | — | — | -$0.25 | — | — | — |
| Q3 2024 Aug 9, 2024 | — | $611.50K | — | — | -$0.42 | — | — | — |
| Q2 2024 May 20, 2024 | — | $646.63K | — | — | -$0.32 | — | — | — |
| Q2 2024 Apr 16, 2024 | — | $531.46K | — | — | $0.29 | — | — | — |
| Q4 2023 Nov 20, 2023 | — | $477.46K | — | -$0.17 | -$1.06 | -523.53% | — | — |
| Q3 2023 Aug 18, 2023 | — | $646.02K | — | — | -$0.37 | — | — | — |
| Q3 2023 Aug 11, 2023 | — | $805.11K | — | — | -$0.35 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $613.08K | — | — | -$0.00 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $618.80K | — | — | -$0.25 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $682.58K | — | — | -$0.18 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $770.27K | — | — | -$0.10 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $466.77K | — | — | -$0.16 | — | — | — |